Modulation of tumor necrosis factor and interleukin-1-dependent NF-κB activity by mPLK/IRAK

55Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The innate immune response is an important defense against pathogenic agents. A component of this response is the NF-κB-dependent activation of genes encoding inflammatory cytokines such as interleukin-8 (IL-8) and cell adhesion molecules like E-selectin. Members of the serine/threonine innate immune kinase family of proteins have been proposed to mediate the innate immune response. One serine/threonine innate immune kinase family member, the mouse Pelle-like kinase/human interleukin-1 receptor-associated kinase (mPLK/IRAK), has been proposed to play an obligate role in promoting IL-1- mediated inflammation. However, it is currently unknown whether mPLK/IRAK catalytic activity is required for IL-1-dependent NF-κB activation. The present study demonstrates that mPLK/IRAK catalytic activity is not required for IL-1-mediated activation of an NF-κB-dependent signal. Intriguingly, catalytically inactive mPLK/IRAK inhibits type 1 tumor necrosis factor (TNF) receptor-dependent NF-κB activation. The pathway through which mPLK/IRAK mediates this TNF response is TRADD- and TRAF2-independent. Our data suggest that in addition to its role in IL-1 signaling, mPLK/IRAK is a component of a novel signal transduction pathway through which TNF R1 activates NF-κB- dependent gene expression.

Cite

CITATION STYLE

APA

Vig, E., Green, M., Liu, Y., Donner, D. B., Mukaida, N., Goebl, M. G., & Harrington, M. A. (1999). Modulation of tumor necrosis factor and interleukin-1-dependent NF-κB activity by mPLK/IRAK. Journal of Biological Chemistry, 274(19), 13077–13084. https://doi.org/10.1074/jbc.274.19.13077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free